1
|
Moftah HK, Mousa MHA, Elrazaz EZ, Kamel AS, Lasheen DS, Georgey HH. Novel quinazolinone Derivatives: Design, synthesis and in vivo evaluation as potential agents targeting Alzheimer disease. Bioorg Chem 2024; 143:107065. [PMID: 38150939 DOI: 10.1016/j.bioorg.2023.107065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 12/02/2023] [Accepted: 12/23/2023] [Indexed: 12/29/2023]
Abstract
Since Alzheimer disease is one of the most prevalent types of dementia with a high mortality and disability rate, so development of multi-target drugs becomes the major strategy for battling AD. This study shows the development of a series of quinazolinone based derivatives as novel, multifunctional anti-AD drugs that exhibit both cholinesterase inhibitoryand anti-inflammatory properties. The preliminary results of the in vitro AChE inhibition activity showed that compounds 4b, 5a, 6f, 6h and 7b were better represented for further evaluation. Furthermore, in-vivo AChE inhibition activity and behavior Morris water maze test against donepezil as reference drug were evaluated. Additionally, hippocampal inflammatory markers; TNF-α, NFĸB, IL-1β and IL-6 and antioxidant markers; SOD and MDA were assessed to evaluate the efficacy of quinazolinone derivatives against AD hallmarks. The results showed that 6f, 6h and 7b have promising anti-acetylcholinesterase, anti-inflammatory and antioxidant activities thus, have a significant effect in treatment of AD. Moreover, Histopathological examination revealed that 6f, 6h and 7b derivatives have neuroprotective effect against neuronal damage caused by induced scopolamine model in mice. Finally, the binding ability of the synthesized derivatives to the target, AChE was investigated through molecular docking which reflected significant interactions to the target based on their docking binding scores. Hence, the newly designed quinazolinone derivatives possess promising anti-acetylcholinesterase activity and challenging for the management of AD in the future.
Collapse
Affiliation(s)
- Hadeer K Moftah
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, Gesr El Suez st, PO 11786, Cairo, Egypt
| | - Mai H A Mousa
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, Gesr El Suez st, PO 11786, Cairo, Egypt
| | - Eman Z Elrazaz
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, African Union Organization Street, Cairo 11566, Egypt
| | - Ahmed S Kamel
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo P.O. Box 11562, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, Gesr El Suez st, PO 11786 Cairo, Egypt
| | - Deena S Lasheen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, African Union Organization Street, Cairo 11566, Egypt
| | - Hanan H Georgey
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo P.O. Box 11562, Egypt.
| |
Collapse
|
2
|
Jongcharoenkamol J, Naksing P, Nimnuan N, Singh T, Chatwichien J, Temkitthawon P, Sriwattanawarunyoo C, Choommongkol V, Meepowpan P, Kerdphon S. Microwave-assisted commercial copper-catalyzed aerobic oxidative synthesis of AChE quinazolinone inhibitors under solvent free conditions. RSC Adv 2023; 13:27657-27662. [PMID: 37727584 PMCID: PMC10506383 DOI: 10.1039/d3ra05739a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 09/11/2023] [Indexed: 09/21/2023] Open
Abstract
A facile and green one-pot synthesis of AChE quinazolinone inhibitors was developed using microwave irradiation under solvent free conditions. Quinazolinones were synthesized from 2-aminobenzamide derivatives and various alcohols such as benzyl alcohol derivatives and butanol using economical commercially available copper as a catalyst in the presence of base, Cs2CO3. The desired products were achieved in moderate to high yields with up to 92% isolated yield. These quinazolinone products were then evaluated for acetylcholinesterase inhibition so that they can be developed as promising anti-acetylcholinesterase agents.
Collapse
Affiliation(s)
- Jira Jongcharoenkamol
- Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Science, Naresuan University Phitsanulok 65000 Thailand
- Center of Excellence in Cannabis Research, Faculty of Pharmaceutical Sciences, Naresuan University Phitsanulok 65000 Thailand
| | - Prakansi Naksing
- Department of Chemistry, Faculty of Science, Naresuan University Phitsanulok 65000 Thailand
| | - Nattayaporn Nimnuan
- Department of Chemistry, Faculty of Science, Naresuan University Phitsanulok 65000 Thailand
| | - Thishana Singh
- School of Chemistry and Physics, University of Kwazulu-Natal Private Bag X54001 Durban 4000 South Africa
| | - Jaruwan Chatwichien
- Program in Chemical Sciences, Chulabhorn Graduate Institute, Chulabhorn Royal Academy Bangkok 10210 Thailand
| | - Prapapan Temkitthawon
- Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Science, Naresuan University Phitsanulok 65000 Thailand
- Center of Excellence in Cannabis Research, Faculty of Pharmaceutical Sciences, Naresuan University Phitsanulok 65000 Thailand
| | | | - Vachira Choommongkol
- Department of Chemistry, Faculty of Science, Maejo University Chiang Mai 50290 Thailand
| | - Puttinan Meepowpan
- Department of Chemistry, Faculty of Science, Chiang Mai University Chiang Mai 50200 Thailand
- Center of Excellence in Material Science and Technology, Chiang Mai University Chiang Mai 50200 Thailand
| | - Sutthichat Kerdphon
- Center of Excellence in Cannabis Research, Faculty of Pharmaceutical Sciences, Naresuan University Phitsanulok 65000 Thailand
- Department of Chemistry, Faculty of Science, Naresuan University Phitsanulok 65000 Thailand
- Center of Excellence in Petroleum, Petrochemicals and Advanced Materials, Faculty of Science, Naresuan University Phitsanulok 65000 Thailand
| |
Collapse
|
3
|
Access to new phosphonate- and imidazolidine-benzopyrimidinone derivatives as antityrosinase and anti-acetylcholinesterase agents: Design, synthesis and molecular docking. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.133693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
4
|
Zhang C, Wang Y, Jiang Y, Zhang Y, Xie Y, Gong R, Hao Q. Substituent Effect: Synthesis of Three TNP‐Detecting Fluorescent Probes Based on Triazolothiadiazole‐Quinazolinone**. ChemistrySelect 2022. [DOI: 10.1002/slct.202200198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Chenglu Zhang
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| | - Yiming Wang
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| | - Yanhua Jiang
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| | - Yining Zhang
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| | - Yanxuan Xie
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| | - Rongqing Gong
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| | - Qiang Hao
- School of Chemistry and Chemical Engineering Liaoning Normal University Dalian 116029 P. R. China
| |
Collapse
|
6
|
Mohammadi-Khanaposhtani M, Nori M, Valizadeh Y, Javanshir S, Dastyafteh N, Moaazam A, Hosseini S, Larijani B, Adibi H, Biglar M, Hamedifar H, Mahdavi M, Kamci H, Karakus A, Taslimi P. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes. Arch Pharm (Weinheim) 2022; 355:e2100313. [PMID: 35132681 DOI: 10.1002/ardp.202100313] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Revised: 12/27/2021] [Accepted: 01/19/2022] [Indexed: 11/11/2022]
Abstract
A series of novel 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids (6a-n) was designed, synthesized, and evaluated for their in vitro inhibitory activity against the metabolic enzymes, acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glucosidase. The obtained results showed that most of the synthesized compounds exhibited high to good anti-AChE and anti-BChE activity in the range of nanomolar concentrations in comparison to tacrine as a positive control. Molecular modeling of the most potent compounds 6e and 6i demonstrated that these compounds interacted with important residues of the AChE and BChE active sites. Moreover, all the newly synthesized compounds 6a-n had significant Ki values against α-glucosidase when compared with the positive control acarbose. Representatively, N-2-fluorophenylacetamide derivative 6l, with a Ki value of 0.98 nM as the most potent compound, was 126 times more potent than acarbose with a Ki value of 123.70 nM. This compound also fitted in the α-glucosidase active site and interacted with key residues. An in silico study of the druglikeness/absorption, distribution, metabolism, and excretion (ADME)/toxicity profile of the selected compounds 6e, 6i, and 6l predicts that these compounds are drug-like and have the appropriate properties in terms of ADME and toxicity.
Collapse
Affiliation(s)
- Maryam Mohammadi-Khanaposhtani
- Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
| | - Milad Nori
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Yousef Valizadeh
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Shahrzad Javanshir
- Department of Chemistry, Iran University of Science and Technology, Tehran, Iran
| | - Navid Dastyafteh
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Ali Moaazam
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Bagher Larijani
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Hossein Adibi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Mahmood Biglar
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Haleh Hamedifar
- CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Hamdi Kamci
- Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
| | - Ahmet Karakus
- Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
| | - Parham Taslimi
- Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
| |
Collapse
|